Top Markets
Coin of the day
AegirBio AB (publ) AegirBio AB (publ)

AegirBio AB (publ)

AEGIR
Classement en actions #38668
AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden.... AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden. The company specializes in developing and commercializing tests primarily aimed at monitoring the dosage of biological drugs. Their efforts are concentrated on therapeutic drug monitoring for biologic therapies across various conditions, including multiple sclerosis, different types of cancer, and autoimmune diseases. Among their offerings are moNATor, a pioneering laboratory test designed for dose monitoring in multiple sclerosis for both medical professionals and patients, and Viraspec, a saliva-based test kit for COVID-19 detection.
Prix de l'action
$0.04057595
Dernière synchronisation: 2024-08-05
Capitalisation boursière
$863.62K
Changement (1 jour)
0.31%
Changement (1 an)
0.00%
Pays
SE
Échange AegirBio AB (publ) (AEGIR)

Catégorie

Ratio P/S pour AegirBio AB (publ) (AEGIR)
Ratio P/S au August 2026 TTM : 167.72
Selon les derniers rapports financiers et le cours de l'action de AegirBio AB (publ), le ratio cours/ventes actuel (TTM) est 167.72. À la fin de 2022, le ratio P/S était de 22.63.
Historique du ratio P/S pour AegirBio AB (publ) de 2019 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
2026 (TTM) 167.72 -47.36%
2023 318.62 1,307.72%
2022 22.63 -67.86%
2021 70.42 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
11.31 -93.26%
US
2.57 -98.46%
FR
- -
JP
2.81 -98.33%
US
- -
CH